Ameriprise Financial Inc Codexis, Inc. Transaction History

Ameriprise Financial Inc

  • $364 Billion
  • Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 2,002,745 shares of CDXS stock, worth $6.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,002,745
Previous 1,299,073 54.17%
Holding current value
$6.99 Million
Previous $4.53 Million 36.95%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.65 - $3.92 $1.86 Million - $2.76 Million
703,672 Added 54.17%
2,002,745 $6.21 Million
Q1 2024

May 15, 2024
BUY
$2.59 - $4.65 $173,271 - $311,085
66,900 Added 5.43%
1,299,073 $4.53 Million
Q4 2023

Feb 14, 2024
SELL
$1.54 - $3.37 $855,422 - $1.87 Million
-555,469 Reduced 31.07%
1,232,173 $3.76 Million
Q3 2023

Nov 14, 2023
BUY
$1.5 - $3.75 $1.62 Million - $4.05 Million
1,081,197 Added 153.05%
1,787,642 $3.38 Million
Q2 2023

Aug 14, 2023
SELL
$2.21 - $4.43 $181,662 - $364,146
-82,200 Reduced 10.42%
706,445 $1.98 Million
Q1 2023

May 15, 2023
SELL
$3.81 - $6.76 $104,504 - $185,420
-27,429 Reduced 3.36%
788,645 $3.26 Million
Q4 2022

Feb 14, 2023
SELL
$4.26 - $6.84 $4.88 Million - $7.83 Million
-1,144,814 Reduced 58.38%
816,074 $3.8 Million
Q3 2022

Nov 14, 2022
BUY
$6.06 - $12.86 $2.17 Million - $4.6 Million
358,022 Added 22.34%
1,960,888 $11.9 Million
Q2 2022

Aug 15, 2022
SELL
$8.35 - $21.89 $9.59 Million - $25.1 Million
-1,148,573 Reduced 41.74%
1,602,866 $16.8 Million
Q1 2022

May 16, 2022
BUY
$16.97 - $31.93 $6.93 Million - $13 Million
408,417 Added 17.43%
2,751,439 $56.7 Million
Q4 2021

Feb 14, 2022
BUY
$25.61 - $41.78 $8.11 Million - $13.2 Million
316,610 Added 15.62%
2,343,022 $73.3 Million
Q3 2021

Nov 15, 2021
BUY
$19.65 - $27.99 $7.81 Million - $11.1 Million
397,326 Added 24.39%
2,026,412 $47.2 Million
Q2 2021

Aug 16, 2021
BUY
$17.48 - $25.46 $10.6 Million - $15.5 Million
606,982 Added 59.39%
1,629,086 $36.9 Million
Q1 2021

May 17, 2021
SELL
$18.08 - $28.8 $25,583 - $40,752
-1,415 Reduced 0.14%
1,022,104 $23.4 Million
Q4 2020

Feb 12, 2021
BUY
$11.7 - $23.41 $3.03 Million - $6.07 Million
259,100 Added 33.9%
1,023,519 $22.3 Million
Q3 2020

Nov 16, 2020
SELL
$11.21 - $13.82 $504 - $621
-45 Reduced 0.01%
764,419 $8.98 Million
Q2 2020

Aug 14, 2020
BUY
$9.8 - $12.77 $9,702 - $12,642
990 Added 0.13%
764,464 $8.72 Million
Q1 2020

May 15, 2020
BUY
$8.78 - $18.6 $359,839 - $762,302
40,984 Added 5.67%
763,474 $8.52 Million
Q4 2019

Feb 14, 2020
BUY
$13.12 - $17.06 $1.16 Million - $1.51 Million
88,777 Added 14.01%
722,490 $11.6 Million
Q3 2019

Nov 14, 2019
BUY
$12.75 - $19.01 $2.23 Million - $3.32 Million
174,764 Added 38.08%
633,713 $8.69 Million
Q2 2019

Aug 14, 2019
SELL
$17.0 - $21.88 $2.05 Million - $2.64 Million
-120,738 Reduced 20.83%
458,949 $8.46 Million
Q1 2019

May 15, 2019
BUY
$15.53 - $22.15 $1.82 Million - $2.59 Million
117,043 Added 25.3%
579,687 $11.9 Million
Q4 2018

Feb 14, 2019
BUY
$14.06 - $22.57 $1.26 Million - $2.03 Million
89,795 Added 24.08%
462,644 $7.73 Million
Q3 2018

Nov 14, 2018
BUY
$13.35 - $19.1 $3.14 Million - $4.49 Million
234,909 Added 170.3%
372,849 $6.4 Million
Q2 2018

Aug 14, 2018
BUY
$10.35 - $16.45 $125,649 - $199,703
12,140 Added 9.65%
137,940 $1.99 Million
Q1 2018

May 15, 2018
BUY
$8.0 - $12.8 $242,400 - $387,840
30,300 Added 31.73%
125,800 $1.38 Million
Q4 2017

Feb 12, 2018
BUY
$5.85 - $8.4 $558,675 - $802,200
95,500
95,500 $798,000

Others Institutions Holding CDXS

# of Institutions
123
Shares Held
48.7M
Call Options Held
33.7K
Put Options Held
20.2K
View Full List

About CODEXIS, INC.

CDXS Quotes by TradingView
  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $229M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email